Coleman, Damon L. – Trademark Portfolio
Entity Type: 01
Coleman, Damon L. has 3 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 2 are successfully registered — a 67% registration rate. The portfolio includes marks such as DOOERNOMICS 101 and AMADOOER DOMINATE. Filings span 3 Nice Classification classes, with the highest activity in Class 35 (Advertising & Business) and Class 41 (Education & Entertainment). This trademark owner is based in PHILADELPHIA, PA.
1529 Roselyn St Philadelphia PA 19141
2031 66th Ave P.O. Box 20779
PHILADELPHIA, PA 19138
Showing of trademarks Trademarks
Trademark Classifications
Coleman, Damon L.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Coleman, Damon L. have?
Coleman, Damon L. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.
What trademark classes does Coleman, Damon L. file in?
Coleman, Damon L. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.
What are Coleman, Damon L.'s most well-known trademarks?
Coleman, Damon L.'s registered trademark portfolio includes well-known marks such as DOOERNOMICS 101 and AMADOOER DOMINATE. These are among 2 currently registered trademarks in the portfolio.
What is Coleman, Damon L.'s trademark registration success rate?
Coleman, Damon L. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.